Not hospitalized (n = 959) | Hospitalized (n = 41) | OR (95 % CI) | p-value | |
---|---|---|---|---|
Age, mean ± SD, median (IQR) | 12.1 ± 6.0, 14.1 (7.4–17.3) | 10.0 ± 7.7, 12.2 (0.9–17.1) | 0.95 (0.90-1.00) | 0.077b |
Male gender | 459 (47.9 %) | 18 (43.9 %) | 0.9 (0.5–1.6) | 0.619a |
Race | 0.086a | |||
White | 760 (79.2 %) | 29 (70.7 %) | Reference | |
Black | 118 (12.3 %) | 10 (24.4 %) | 2.2 (1.1–4.7) | |
Asian | 41 (4.3 %) | 2 (4.9 %) | 1.3 (0.3–5.5) | |
Other | 40 (4.2 %) | 0 (0.0 %) | 0.0 (0.0-∞) | |
Hispanic | 188 (19.6 %) | 15 (36.6 %) | 2.4 (1.2–4.6) | 0.008a |
Black or Hispanic | 304 (31.7 %) | 25 (61.0 %) | 3.4 (1.8–6.4) | < 0.001a |
Body mass index, mean ± SD, median, BMI Category | 21.9 ± 5.5, 21.0 (18.0-24.4) | 22.5 ± 7.7, 20.9 (16.1–25.6) | 1.02 (0.96–1.08) | 0.849b 0.435a |
Underweight | 153 (28.4 %) | 12 (35.3 %) | 1.49 (0.67–3.3) | |
Normal weight | 266 (49.4 %) | 14 (41.2 %) | Reference | |
Overweight | 72 (13.4 %) | 3 (8.8 %) | 0.79 (0.22–2.83) | |
Obese | 47 (8.7 %) | 5 (14.7 %) | 2.02 (0.70–5.88) | |
Clinical Symptoms | 0.229a | |||
Anosmia (loss of smell) | 162 (16.9 %) | 4 (9.8 %) | 0.5 (0.2–1.5) | |
Shortness of breath(dyspnea) | 81 (8.4 %) | 17 (41.5 %) | 7.7 (4.0-14.9) | < 0.001a |
Sore throat | 357 (37.2 %) | 4 (9.8 %) | 0.2 (0.1–0.5) | < 0.001a |
Vomiting | 12 (1.3 %) | 4 (9.8 %) | 8.5 (2.6–27.7) | < 0.001a |
Fever > 100.4 F | 314 (32.7 %) | 23 (56.1 %) | 2.6 (1.4–4.9) | 0.002a |
Headache | 420 (43.8 %) | 4 (9.8 %) | 0.2 (0.05–0.39) | < 0.001a |
Hypoxia | 1 (0.1 %) | 11 (26.8 %) | 351.3 (43.9-2809.2) | < 0.001a |
Abdominal pain | 74 (7.7 %) | 8 (19.5 %) | 2.9 (1.3–6.5) | 0.007a |
Nausea or vomiting | 139 (14.5 %) | 8 (19.5 %) | 1.4 (0.6–3.2) | 0.374 a |
Pre-existing condition(s) | 150 (15.6 %) | 27 (65.9 %) | 10.4 (5.3–20.3) | < 0.001a |
Immunocompromising condition | 4 (0.4 %) | 5 (12.2 %) | 33.2 (8.5-128.7) | < 0.001a |
Neurologic condition | 24 (2.5 %) | 9 (22.0 %) | 11.0 (4.7–25.5) | < 0.001a |
Cardiovascular disease | 19 (2.0 %) | 8 (19.5 %) | 12.0 (4.9–29.4) | < 0.001a |
Chronic renal disease | 5 (0.5 %) | 3 (7.3 %) | 15.1 (3.5–65.4) | < 0.001a |
Chronic lung disease | 69 (7.2 %) | 8 (19.5 %) | 3.1 (1.4-7.0) | < 0.004a |
Diabetes | 9 (0.9 %) | 1 (2.4 %) | 2.6 (0.3–21.3) | < 0.344a |
Other chronic condition | 53 (5.5 %) | 11 (26.8 %) | 6.3 (3.0-13.2) | < 0.001a |